First Eagle Investment Management
ACHV icon

First Eagle Investment Management’s Achieve Life Sciences ACHV Stock Holding History

First Eagle Investment Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-234
Closed -$1.18M – 334
2014
Q4 		$1.18M Hold
234
– – ﹤0.01% 228
2014
Q3 		$1.38M Sell
234
-27
-10% -$188K ﹤0.01% 223
2014
Q2 		$2.14M Buy
+261
New +$3.21M 0.01% 216

Other funds holding ACHV

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

First Eagle Investment Management's ACHV Position: Q1 2015 in Review

First Eagle Investment Management sold out of Achieve Life Sciences (ACHV) in Q1 2015, closing a stake of 234 shares — an estimated $1.18M sold.

First Eagle Investment Management first reported a position in ACHV in Q2 2014 and held it in 3 quarters. The position peaked at $2.14M in Q2 2014. 49 funds tracked by Wall St. Rank hold ACHV as of Q1 2015.

  • First Eagle Investment Management reported no remaining Achieve Life Sciences position as of Q1 2015 after selling out during the quarter.
  • First Eagle Investment Management sold 234 Achieve Life Sciences shares in Q1 2015, an estimated $1.18M.
  • First Eagle Investment Management first reported a position in Achieve Life Sciences in Q2 2014 and held it in 3 quarters.
  • First Eagle Investment Management's Achieve Life Sciences position peaked at $2.14M in Q2 2014.
  • 49 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2015.

Based on First Eagle Investment Management's 13F filing for Q1 2015, filed 7 May 2015.